Highest-materiality recent filing
Pilgrim's Pride Q1 net income $101.5M, EPS $0.43 vs $1.24 YoY; margins compress
GAAP EPS $0.43, down 65% from $1.24; adjusted EPS $0.51.
Pilgrim's Pride Q4 GAAP EPS $0.37 vs $0.99 YoY; FY2025 net sales $18.5B
Q4 net sales $4.52B (+3.3% YoY); GAAP operating income $204M (-33.4%); GAAP EPS $0.37 (-62.6%).
Pilgrim's Pride Q3 2025: net sales $4.8B (+3.8% YoY), GAAP EPS $1.44
Net sales $4.8B (+3.8% YoY); GAAP EPS $1.44, adjusted EPS $1.52.
Pilgrim's Pride Q2 net sales $4.8B, GAAP EPS $1.49, declares $2.10 special dividend
Net sales $4.757B (+4.3% YoY); GAAP operating income $512.3M (+16.2% YoY).
Pilgrim's Pride Q1 2025: revenue $4.46B, EPS $1.24, operating income up 61.6%
Net sales $4.463B (+2.3% YoY); GAAP operating margin 9.1%; net income $296.3M.
Pilgrim's Pride declares $1.5B special dividend ($6.30/share) alongside long-term capital strategy
Special cash dividend of $6.30 per share (~$1.5B total) payable April 17, 2025 to holders of record April 3, 2025.
Pilgrim's Pride Q4 GAAP EPS $0.99, up 74% YoY; adj. EBITDA margin 12.0%
Q4 GAAP EPS $0.99 vs $0.57 YoY (+73.7%); adj. EPS $1.35; net sales $4.37B (-3.5%).
Pilgrim's Pride stockholders approve charter change; enters tax pact with JBS
Stockholders approved certificate amendment with 96% of outstanding shares voting for; effective Dec 30, 2024.
Pilgrim's Pride Q3 net sales $4.585B, GAAP EPS $1.47, adj. EPS $1.63, operating income up 146% YoY
Net sales of $4.585B (+5.2% YoY); GAAP operating income $508.4M (11.1% margin) vs $206.4M a year ago.
Pilgrim's Pride reports Q2 2024: net sales $4.6B, operating income $440.8M, adjusted EPS $1.67
Q2 GAAP net income $326.5M ($1.37 EPS); adjusted net income $398.0M ($1.67 EPS).
Pilgrim's Pride Q1 EPS $0.73 vs $0.02 YoY; net sales $4.36B +4.7%
GAAP net income $174.9M ($0.73 EPS); adjusted EPS $0.77; operating income $250.3M, up 699.7%.
On February 4, 2025, pursuant to the Company’s Amended and Restated Certificate of Incorporation (“Certificate of Incorporation”) and Amended and Restated Bylaws (“Bylaws”), the JBS Nominating Committee (the “JBS Nominating Committee”) of the Board of Directors (the “Board”) appointed Joanita Karoleski to the Board as a JBS Director.
In addition, Mr. Menon was re-appointed to the Board and re-classified by the JBS Nominating Committee from an Equity Director to a JBS Director.
Max materiality 0.90 · Median 0.40 · Most common event earnings